Evidence map›Paper›PMID 40042504›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements.

Huitong Ding, Zehao Ye, Aris Paschalidis, David A Bennett, Rhoda Au, Honghuang Lin

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The value of machine learning models in differentiating alzheimer's disease from Moderate-to-Severe cerebral small vessel disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Article
  4. Article
  5. Dynamic lifetime risk prediction of Alzheimer's disease with longitudinal cognitive assessment measurements.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huitong DingDepartment of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Zehao YeDepartment of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Aris PaschalidisDepartment of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Rhoda AuDepartment of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Honghuang LinDepartment of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Validating novel sleep sensors and devices in older adults with Alzheimer's diseaseP30AG073107 · NIA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI Benjamin M. Marlin · 2021 to 2026
$32.0M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Social and behavioral determinants of health and Alzheimer’s Disease: Cohort study of the US military veteran populationR01AG080670 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI HONG YU · 2023 to 2026
$4.5M
Epigenetic changes in synaptic and inflammatory genes involved in the age-dependent development of Alzheimer's disease pathologies andcognitive declineRF1AG054156 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, RYU, HOON · 2016 to 2018
$3.4M
Assessing Alzheimer disease risk and heterogeneity using multimodal machine learning approachesU01AG068221 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DESTEFANO, ANITA L, LIN, HONGHUANG · 2021 to 2024
$2.5M
Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related DementiasR01AG083735 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2024 to 2026
$2.4M
Sleep pathology and cardiac agingR21HL175584 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIN, HONGHUANG, THOMAS, ROBERT JOSEPH · 2024 to 2025
$233k
Alzheimer's Association AARG-NTF-20-643020American Heart Association 20SFRN35360180Defense Advanced Research Projects Agency FA8750-16-C-0299NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS R21 HL175584NHLBI NIH HHS R21HL175584NIA NIH HHS AG-008122NIA NIH HHS AG-049810NIA NIH HHS AG054156NIA NIH HHS AG-062109NIA NIH HHS AG-068753NIA NIH HHS AG-16495NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS P30 AG073107NIA NIH HHS P30AG073107NIA NIH HHS P30AG10161NIA NIH HHS P30AG72975NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG080670NIA NIH HHS R01AG080670NIA NIH HHS R01 AG083735NIA NIH HHS R01AG083735NIA NIH HHS R01AG15819NIA NIH HHS R01AG17917NIA NIH HHS RF1 AG054156NIA NIH HHS U01 AG068221NIA NIH HHS U01AG068221NINDS NIH HHS NS017950NINDS NIH HHS R01 NS017950
6 · The paper itself

Abstract

introductionThe progressive nature of Alzheimer's disease (AD) highlights the importance of predicting lifetime risk and updating assessments as new data emerge. This study aimed to develop a dynamic model using longitudinal cognitive assessments for updated risk predictions.

methodsThis study used data from the Religious Orders Study and the Rush Memory and Aging Project (ROSMAP) to develop a dynamic risk prediction model based on five cognitive domains, updated annually over 10 years.

resultsThe lifetime prediction models based on 2384 participants showed improved area under the curve (AUC) over time, rising from 0.578 at baseline to 0.765 with 10 years of data. The models predicting AD onset before ages 85 and 90 showed superior performance, with AUCs increasing from 0.761 to 0.932 and 0.658 to 0.876, respectively. DISCUSSION: Incorporating longitudinal cognitive assessments improves AD risk prediction as more data become available. Future research should integrate diverse data types to further boost predictive accuracy. HIGHLIGHTS: Developed a dynamic lifetime risk prediction model. The area under the curve (AUC) increased from 0.578 at baseline to 0.765 with 10 years of data. The models predicting pre-85 and pre-90 risks demonstrated superior performance.

Indexed as

Alzheimer DiseaseCognitionNeuropsychological TestsAgedAged, 80 and overFemaleHumansLongitudinal StudiesMaleRisk AssessmentRisk FactorsAlzheimer's diseasecognitive assessmentdynamic risk prediction

Identifiers

PMID40042504
PMCPMC11881628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.